Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Abel

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Oecologia|March 18, 2017
Thievery, home ranges, and nestmate recognition inEctatomma ruidumMichael D Breed, Paul Abel, Tony J Bleuze, et al.
Neoplasia (New York, N.Y.)|March 28, 2003
Androgen-independent prostate cancer: potential role of androgen and ErbB receptor signal transduction crosstalkSoha Salama El Sheikh, Jan Domin, Paul Abel, et al.
Oncology & Hematology Review|June 17, 2014
Androgen Deprivation Therapy and the Re-emergence of Parenteral Estrogen in Prostate CancerIain Phillips, Syed I A Shah, Trinh Duong, et al.
Neoplasia (New York, N.Y.)|February 22, 2005
Phosphorylation of both EGFR and ErbB2 is a reliable predictor of prostate cancer cell proliferation in response to EGFSoha Salama El Sheikh, Jan Domin, Paul Abel, et al.
Neoplasia (New York, N.Y.)|August 21, 2008
Predictive value of PTEN and AR coexpression of sustained responsiveness to hormonal therapy in prostate cancer--a pilot studySoha Salama El Sheikh, Hanna M Romanska, Paul Abel, et al.
Neoplasia (New York, N.Y.)|April 2, 2002
Androgen-dependent regulation of human MUC1 mucin expressionStephen Mitchell, Paul Abel, Sanjeev Madaan, et al.
BMC Clinical Pathology|October 18, 2003
Topographical expression of class IA and class II phosphoinositide 3-kinase enzymes in normal human tissues is consistent with a role in differentiationSoha Salama El Sheikh, Jan Domin, Prakitpunthu Tomtitchong, et al.
BJU International|February 2, 2018
Transdermal oestradiol as a method of androgen suppression for prostate cancer within the STAMPEDE trial platformDuncan C Gilbert, Trinh Duong, Matthew Sydes, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Oecologia|March 18, 2017
Thievery, home ranges, and nestmate recognition inEctatomma ruidumMichael D Breed, Paul Abel, Tony J Bleuze, et al.
Neoplasia (New York, N.Y.)|March 28, 2003
Androgen-independent prostate cancer: potential role of androgen and ErbB receptor signal transduction crosstalkSoha Salama El Sheikh, Jan Domin, Paul Abel, et al.
Oncology & Hematology Review|June 17, 2014
Androgen Deprivation Therapy and the Re-emergence of Parenteral Estrogen in Prostate CancerIain Phillips, Syed I A Shah, Trinh Duong, et al.
Neoplasia (New York, N.Y.)|February 22, 2005
Phosphorylation of both EGFR and ErbB2 is a reliable predictor of prostate cancer cell proliferation in response to EGFSoha Salama El Sheikh, Jan Domin, Paul Abel, et al.
Neoplasia (New York, N.Y.)|August 21, 2008
Predictive value of PTEN and AR coexpression of sustained responsiveness to hormonal therapy in prostate cancer--a pilot studySoha Salama El Sheikh, Hanna M Romanska, Paul Abel, et al.
Neoplasia (New York, N.Y.)|April 2, 2002
Androgen-dependent regulation of human MUC1 mucin expressionStephen Mitchell, Paul Abel, Sanjeev Madaan, et al.
BMC Clinical Pathology|October 18, 2003
Topographical expression of class IA and class II phosphoinositide 3-kinase enzymes in normal human tissues is consistent with a role in differentiationSoha Salama El Sheikh, Jan Domin, Prakitpunthu Tomtitchong, et al.
BJU International|February 2, 2018
Transdermal oestradiol as a method of androgen suppression for prostate cancer within the STAMPEDE trial platformDuncan C Gilbert, Trinh Duong, Matthew Sydes, et al.
Pageof 2